Acalabrutinib 100 mg (Generic)

What is Acalabrutinib 100 mg?

Acalabrutinib 100 mg is a prescription medication primarily used to treat certain types of blood cancer. Developed by Natco Pharma Ltd., this medication is widely prescribed to patients suffering from conditions like mantle cell lymphoma and chronic lymphocytic leukemia in the UK. It belongs to a class of drugs that specifically target cancerous cells, making it a focused treatment option for blood malignancies.

This medicine contains the active ingredient acalabrutinib, which works by disrupting the signals that promote cancer cell growth. It is an oral therapy, taken in capsule form, designed to provide effective treatment with manageable side effects. Acalabrutinib 100 mg offers a critical option for patients looking for targeted cancer therapies.

Uses of Acalabrutinib 100 mg

• Treatment of mantle cell lymphoma (MCL)
• Management of chronic lymphocytic leukemia (CLL)
• Therapeutic option for relapsed or refractory blood cancers
• Alternative to chemotherapy for certain blood cancer patients

How Acalabrutinib 100 mg Works

Acalabrutinib is a selective Bruton’s tyrosine kinase (BTK) inhibitor. BTK is an enzyme critical for the survival and proliferation of B-cell cancers. By inhibiting BTK, Acalabrutinib interrupts the signaling pathways that allow cancerous B cells to multiply and survive. This targeted mechanism helps reduce cancer cell growth and promotes their death, thereby controlling the progression of blood cancer.

The focus on BTK inhibition means Acalabrutinib 100 mg can specifically affect malignant cells with minimal impact on normal cells, offering a more tailored approach to blood cancer treatment compared to traditional chemotherapy.

Benefits of Acalabrutinib 100 mg

• Targeted treatment with fewer systemic side effects
• Oral administration offers convenience over intravenous therapies
• Effective against multiple blood cancers including mantle cell lymphoma and chronic lymphocytic leukemia
• Improves disease control and patient quality of life
• Can be used in patients who have relapsed or are refractory to prior therapies

Dosage and Administration

The usual recommended dose of Acalabrutinib 100 mg is one capsule taken twice daily, approximately every 12 hours, with or without food. It is important to follow the prescribing healthcare provider’s instructions exactly. Capsules should be swallowed whole and not crushed or chewed.

Regular monitoring by your healthcare professional is essential to adjust the dose if necessary based on treatment response and side effects. Patients should not skip doses and must inform their doctor if any dose is missed or if adverse symptoms occur.

Who Should Use Acalabrutinib 100 mg?

Acalabrutinib 100 mg is recommended for adults diagnosed with certain types of blood cancers such as mantle cell lymphoma or chronic lymphocytic leukemia. It is suitable for patients who require targeted therapy and those who have relapsed after or are resistant to previous treatments.

Use under strict medical supervision is advised, ensuring that patients have had appropriate diagnostic workups and assessments.

Who Should Avoid Acalabrutinib 100 mg?

Patients with known hypersensitivity to acalabrutinib or any capsule components should avoid this medication. It is also not recommended for pregnant or breastfeeding women unless specifically advised by a healthcare professional.

People with active infections or serious bleeding disorders should consult their doctor before starting this treatment. In addition, those taking medications that heavily interact with acalabrutinib should avoid concurrent use unless approved by their physician.

Side Effects

• Headache
• Diarrhea
• Fatigue
• Nausea
• Anemia
• Bruising
• Infections
• Cough
• Dizziness
• Bleeding risks

Safety Advice

• Inform your doctor about all medications you are taking
• Report any unusual bleeding or bruising immediately
• Monitor for signs of infection such as fever or persistent cough
• Do not stop medication without consulting your healthcare provider
• Regular blood tests are necessary to monitor your health during treatment
• Avoid grapefruit or grapefruit juice while taking the medication
• Store capsules out of reach of children

Drug Interactions

• Strong CYP3A inhibitors (e.g., ketoconazole)
• Strong CYP3A inducers (e.g., rifampin)
• Anticoagulants and antiplatelet drugs
• Medications affecting heart rhythm
• Other BTK inhibitors

Storage Instructions

Store Acalabrutinib 100 mg capsules at room temperature between 20°C to 25°C (68°F to 77°F). Keep the medicine in its original packaging to protect from moisture and light. Ensure the capsules are stored safely away from children and pets. Do not use after the expiry date printed on the packaging.

Where to buy Acalabrutinib 100 mg in UK?

To buy Acalabrutinib 100 mg in the UK, patients should consult their healthcare provider for a prescription. This medicine is available through licensed pharmacies and specialized oncology suppliers. Always source this medication from authorized pharmacies to guarantee authentic product quality and safe usage.

Frequently Asked Questions (FAQ)

Is Acalabrutinib 100 mg available in UK?

Yes, Acalabrutinib 100 mg is available in the UK by prescription and can be obtained through licensed pharmacies and cancer treatment centers.

What is the price of Acalabrutinib 100 mg in UK?

The price of Acalabrutinib 100 mg in the UK varies depending on the pharmacy and supply, but it is generally covered by the NHS for eligible patients.

What happens if I miss a dose?

If you miss a dose of Acalabrutinib 100 mg, take it as soon as you remember unless it is close to the time for the next dose. Do not double the dose to make up for a missed one.

Where can I find Acalabrutinib 100 mg for sale?

Purchase Acalabrutinib 100 mg only from authorized pharmacies or medical suppliers in the UK with a valid prescription to ensure safety and authenticity.

Can I take Acalabrutinib 100 mg with food?

Acalabrutinib 100 mg capsules can be taken with or without food according to your doctor’s instructions.

Are regular blood tests needed during treatment?

Yes, regular blood tests are necessary to monitor your response to Acalabrutinib and check for any side effects while on treatment.

Can Acalabrutinib 100 mg be used in elderly patients?

Yes, elderly patients can use Acalabrutinib 100 mg, though dosing and monitoring may need adjustment based on the individual’s health status.

Conclusion

Acalabrutinib 100 mg is a modern, targeted therapy designed to treat certain blood cancers effectively with a focus on improving patient outcomes and quality of life. Manufactured by Natco Pharma Ltd., it offers a convenient oral treatment option with a manageable safety profile. Patients in the UK should use this medication under expert medical supervision to gain optimal benefits and minimize risks. When sourced through authorized channels, Acalabrutinib provides a reliable and trusted option for managing challenging blood cancer conditions.